Satellos Bioscience Inc. (MSLE) Balance Sheet
MSLE balance sheet, 2025
December 31, 2025 · U.S. dollars$31.9M assets = $4.1M liabilities + $27.8M equity
Both columns are drawn to the same scale: what MSLE owns equals what it owes plus shareholders’ equity. Hover a block for its value.
MSLE financial health
Descriptive bands, not a rating. Fiscal 2025.
MSLE balance sheet trends, 2015–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $3.9M2015 | $31.9M2025 | +35.1%/yr | |
| Total liabilities | $114,9162015 | $4.1M2025 | +66.7%/yr | |
| Shareholders’ equity | $3.8M2015 | $27.8M2025 | +33.0%/yr | |
| Cash & short-term investments | $3.7M2015 | $27.7M2025 | +33.1%/yr | |
| Working capital | $3.7M2015 | $27.8M2025 | +$24.1M | |
| Current ratio | 33.012015 | 7.772025 | −25.24 |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
MSLE assets
MSLE liabilities and equity
MSLE debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
MSLE balance sheet
| 2025 | 2022 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & short-term investments | $27.7M | $1.9M | $719,151 | $1.0M | $10,107 | $1.1M | $2.4M | $3.7M |
| Cash & equivalents | $9.8M | $1.9M | $709,078 | $1.0M | $10,107 | $1.1M | $2.4M | $2.7M |
| Short-term investments | $17.9M | — | $10,072 | — | — | — | — | $1.0M |
| Receivables | $370,000 | $257,401 | $410,006 | $425,238 | $129,353 | $89,707 | $37,394 | $23,753 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other current assets | $3.8M | $48,513 | $1,142 | $59,893 | $35,003 | $159,988 | $26,391 | $25,399 |
| Total current assets | $31.9M | $2.2M | $1.1M | $1.5M | $174,463 | $1.4M | $2.4M | $3.8M |
| Property, plant & equipment (net) | $5,000 | $8,910 | $1,689 | $6,253 | $3,147 | $1,521 | $3,490 | $5,699 |
| Goodwill & intangible assets | $0 | $3.9M | $0 | $0 | $0 | $0 | $21,681 | $42,546 |
| Long-term investments | $0 | $30,946 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $0 | $4,779 | $1 | $0 | $2 | $1 | $2,845 | $44,084 |
| Total assets | $31.9M | $6.1M | $1.1M | $1.5M | $177,612 | $1.4M | $2.5M | $3.9M |
| Liabilities | ||||||||
| Accounts payable | $1.8M | $1.5M | — | — | — | — | — | — |
| Total current liabilities | $4.1M | $2.8M | $220,457 | $829,639 | $800,134 | $292,512 | $139,244 | $114,916 |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other long-term liabilities | $0 | $0 | $1.1M | $0 | $0 | $0 | $0 | $0 |
| Total liabilities | $4.1M | $2.8M | $1.3M | $829,639 | $800,134 | $292,512 | $139,244 | $114,916 |
| Shareholders' equity | ||||||||
| Common stock & paid-in capital | $85.8M | $29.9M | $4.4M | $30.6M | $28.0M | $28.5M | $28.3M | $28.0M |
| Retained earnings (deficit) | −$82.0M | −$31.3M | −$4.8M | −$38.0M | −$34.9M | −$33.8M | −$32.3M | −$30.5M |
| Accumulated other comprehensive income | −$1.7M | −$6,929 | $1.4M | $1.5M | $2.1M | $2.9M | $2.9M | $2.8M |
| Total shareholders' equity | $27.8M | $3.3M | −$184,251 | $678,670 | −$622,520 | $1.1M | $2.3M | $3.8M |
| Key figures | ||||||||
| Total debt | — | — | $1.1M | — | — | — | — | — |
| Net cash (debt) | — | — | −$376,631 | — | — | — | — | — |
| Working capital | $27.8M | −$591,036 | $909,842 | $672,418 | −$625,671 | $1.1M | $2.3M | $3.7M |
| Tangible book value | $27.8M | −$546,401 | −$184,251 | $678,670 | −$622,520 | $1.1M | $2.3M | $3.7M |
| Current ratio | 7.77 | 0.79 | 5.13 | 1.81 | 0.22 | 4.77 | 17.54 | 33.01 |
| Quick ratio | 6.84 | 0.77 | 5.12 | 1.74 | 0.17 | 4.22 | 17.35 | 32.79 |
| Equity / assets | 87.1% | 54.3% | −16.3% | 45.0% | −350.5% | 79.0% | 94.4% | 97.0% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $61.8M | $70.1M | $27.7M | $34.6M | $38.2M | $41.2M | $27.7M | $33.2M | $39.6M | $44.1M |
| Cash & equivalents | $7.4M | $18.8M | $9.8M | $19.3M | $38.2M | $32.7M | $9.8M | $13.1M | $22.1M | $4.9M |
| Short-term investments | $54.4M | $51.4M | $17.9M | $15.3M | $0 | $8.5M | $17.9M | $20.1M | $17.5M | $39.2M |
| Receivables | $782,060 | $728,387 | $370,000 | $205,000 | $186,000 | $338,000 | $1.0M | $896,561 | $583,048 | $353,880 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other current assets | $3.1M | $4.6M | $3.8M | $2.7M | $2.7M | $2.8M | $510,657 | $212,370 | $152,014 | $79,749 |
| Total current assets | $65.7M | $75.5M | $31.9M | $37.5M | $41.1M | $44.4M | $29.2M | $34.3M | $40.3M | $44.6M |
| Property, plant & equipment (net) | $6,991 | $8,026 | $5,000 | $6,000 | $5,000 | $3,000 | $19,986 | $0 | $19,000 | $19,936 |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $3.9M | $3.9M | $3.9M | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $1 | $0 | $0 | $0 | $0 | $0 | $42,973 | $61,108 | $41,005 | $3.9M |
| Total assets | $65.7M | $75.5M | $31.9M | $37.5M | $41.1M | $44.4M | $33.2M | $38.3M | $44.3M | $48.5M |
| Liabilities | ||||||||||
| Accounts payable | $1.7M | $2.1M | $1.8M | $1.4M | $1.1M | $1.9M | — | — | — | — |
| Total current liabilities | $5.9M | $4.6M | $4.1M | $3.5M | $2.8M | $2.7M | $4.0M | $3.8M | $3.6M | $2.3M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other long-term liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total liabilities | $5.9M | $4.6M | $4.1M | $3.5M | $2.8M | $2.7M | $4.0M | $3.8M | $3.6M | $2.3M |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | $133.8M | $134.3M | $85.8M | $85.5M | $82.5M | $78.1M | $61.9M | $62.0M | $61.9M | $61.7M |
| Retained earnings (deficit) | −$103.3M | −$92.0M | −$82.0M | −$74.7M | −$68.8M | −$63.2M | −$60.4M | −$54.5M | −$47.5M | −$40.8M |
| Accumulated other comprehensive income | $17.6M | $17.7M | −$1.7M | −$1.7M | −$1.7M | −$1.5M | $20.2M | $20.3M | $21.2M | $21.4M |
| Total shareholders' equity | $59.8M | $70.9M | $27.8M | $34.0M | $38.3M | $41.7M | $29.1M | $34.6M | $40.7M | $46.2M |
| Key figures | ||||||||||
| Working capital | $59.8M | $70.9M | $27.8M | $34.0M | $38.3M | $41.7M | $25.2M | $30.6M | $36.7M | $42.2M |
| Tangible book value | $59.8M | $70.9M | $27.8M | $34.0M | $38.3M | $41.7M | $25.2M | $30.6M | $36.8M | $46.2M |
| Book value per share | $2.87 | $3.85 | $1.80 | $2.44 | $2.69 | $3.02 | $3.10 | $3.68 | $4.33 | $4.92 |
| Shares outstanding | 20.8M | 18.4M | 15.5M | 13.9M | 14.3M | 13.8M | 9.4M | 9.4M | 9.4M | 9.4M |
| Current ratio | 11.22 | 16.48 | 7.77 | 10.70 | 14.84 | 16.44 | 7.25 | 9.13 | 11.13 | 19.29 |
| Quick ratio | 10.68 | 15.48 | 6.84 | 9.94 | 13.86 | 15.39 | 7.13 | 9.07 | 11.08 | 19.26 |
| Equity / assets | 91.1% | 93.9% | 87.1% | 90.7% | 93.3% | 93.9% | 87.9% | 90.2% | 91.8% | 95.2% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed December 31, 2025); data from EODHD.
MSLE financial position
At the end of fiscal 2025 (December 31, 2025), Satellos Bioscience had total assets of $31.9 million (up 419.6% from a year earlier), total liabilities of $4.1 million and shareholders' equity of $27.8 million. Its current ratio was 7.77. In the latest quarter (ended June 30, 2026) total assets were $65.7 million and equity $59.8 million.
Related: MSLE income statement, MSLE cash flow statement, MSLE key metrics. See the MSLE stock overview for the latest quote and news.
MSLE balance sheet FAQ
What are Satellos Bioscience's total assets?
Satellos Bioscience reported total assets of $31.9 million at the end of fiscal 2025 (December 31, 2025), compared with $6.1 million a year earlier.
How much cash does Satellos Bioscience have?
Satellos Bioscience held $27.7 million in cash and short-term investments at the end of fiscal 2025.
What is Satellos Bioscience's book value?
Satellos Bioscience's shareholders' equity (book value) was $27.8 million at the end of fiscal 2025.
What is Satellos Bioscience's current ratio?
Satellos Bioscience had current assets of $31.9 million and current liabilities of $4.1 million, a current ratio of 7.77 (it can cover its short-term obligations).